Literature DB >> 9019760

[New microbiological Techniques in diagnosis of tuberculosis].

V I Golyshevskaia1, A A Korneev, L N Chernousova, L G Selina, T A Kazarova, T D Grishina, S G Safonova, V A Puzanov, G M Nikolaeva, N I Fadeeva.   

Abstract

Microbial spectrum in patients with disorders of the upper respiratory tract consisted mainly of streptococci, staphylococci and pneumococci in 1991-1993, 1994 and later, respectively. Most specific for detection of nontuberculous flora was brushing with protecting agar plugs in combination with transport medium and anaerobic culturing. Direct immunofluorescence allows detection of antigens M. chlamydia in 29.4%, M. pneumoniae in 18.5% of cases. In diagnosis of tuberculosis the following new technologies were introduced: bacterioscopy with previous culturing of the material on liquid culture media followed by biological test and polymerase-chain reaction; determination of drug resistance based on nitrate reductase activity of M. tuberculosis indicating resistance of M. tuberculosis on liquid media in 4-7 days, dense egg media in 8-12 days, usage of Popesku medium enables correction of tuberculosis chemotherapy one month after the test initiation; M. tuberculosis identification using Western blot with monoclonal antibodies in some cases for 7 days.

Entities:  

Mesh:

Year:  1996        PMID: 9019760

Source DB:  PubMed          Journal:  Probl Tuberk        ISSN: 0032-9533


  6 in total

1.  Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay.

Authors:  K A Kristian Angeby; Lisbeth Klintz; Sven E Hoffner
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Drug susceptibility testing of Mycobacterium tuberculosis by a nitrate reductase assay applied directly on microscopy-positive sputum samples.

Authors:  Humberto R Musa; Marta Ambroggi; Alejandro Souto; K A Kristian Angeby
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  Impact of rapid drug susceptibility testing for tuberculosis: program experience in Lima, Peru.

Authors:  S S Shin; L Asencios; M Yagui; G Yale; C Suárez; J Bayona; C Bonilla; O Jave; C C Contreras; S Atwood; J A Blaya; J Ershova; J P Cegielski
Journal:  Int J Tuberc Lung Dis       Date:  2012-09-14       Impact factor: 2.373

4.  Evaluation of direct detection of Mycobacterium tuberculosis rifampin resistance by a nitrate reductase assay applied to sputum samples in Cotonou, Benin.

Authors:  Dissou Affolabi; Mathieu Odoun; Anandi Martin; Juan Carlos Palomino; Séverin Anagonou; Françoise Portaels
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

5.  Altered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infection.

Authors:  Yuhua Qi; Lunbiao Cui; Yiyue Ge; Zhiyang Shi; Kangchen Zhao; Xiling Guo; Dandan Yang; Hao Yu; Lan Cui; Yunfeng Shan; Minghao Zhou; Hua Wang; Zuhong Lu
Journal:  BMC Infect Dis       Date:  2012-12-28       Impact factor: 3.090

6.  Evaluation of the performance of nitrate reductase assay for rapid drug-susceptibility testing of mycobacterium tuberculosis in north India.

Authors:  Anamika Gupta; Malay Ranjan Sen; Tribhuban Mohan Mohapatra; Shampa Anupurba
Journal:  J Health Popul Nutr       Date:  2011-02       Impact factor: 2.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.